Spinal cord primitive neuroectodermal tumor

Summary

Spinal cord primitive neuroectodermal tumor (MONDO:0006426) is a cancer. A subtype of central nervous system primitive neuroectodermal neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	spinal cord primitive neuroectodermal tumor
Mondo ID	MONDO:0006426
EFO	EFO:1000545
DOID	DOID:6872
NCIT	C5406
UMLS	C1336048
MedGen	234805
GARD	0027755
Is cancer (heuristic)	yes

Also known as: primitive neuroectodermal neoplasm of spinal cord · primitive neuroectodermal neoplasm of the spinal cord · primitive neuroectodermal tumor of spinal cord · primitive neuroectodermal tumor of the spinal cord · primitive neuroectodermal tumour of spinal cord · primitive neuroectodermal tumour of the spinal cord · spinal cord PNET · spinal cord primitive neuroectodermal neoplasm · spinal cord primitive neuroectodermal tumor

Disease family

This is a subtype of central nervous system primitive neuroectodermal neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › nervous system cancer › central nervous system cancer › central nervous system primitive neuroectodermal neoplasm › spinal cord primitive neuroectodermal tumor

Related subtypes (7): adult central nervous system primitive neuroectodermal neoplasm, childhood central nervous system primitive neuroectodermal neoplasm, intracranial primitive neuroectodermal tumor, spinal cord neuroblastoma, ganglioneuroma, ependymoblastoma, central nervous system tumor with bcor internal tandem duplication

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.